Clinical Trials Directory

Trials / Sponsors / Ansun Biopharma, Inc.

Ansun Biopharma, Inc.

Industry · 10 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
WithdrawnDAS181 for STOP COVID-19
COVID-19
Phase 2 / Phase 32020-07-25
UnknownDAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)
Influenza Infection, SAD-RV Infection and COVID-19
Phase 22020-07-01
RecruitingPhase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT
Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised
Phase 32019-05-23
CompletedA Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompr
Parainfluenza
Phase 22014-03-01
CompletedAn Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized For
Parainfluenza
Phase 22013-08-01
CompletedPhase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenz
Influenza
Phase 22012-11-01
CompletedA Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
Asthma, Bronchiectasis
Phase 12010-07-01
CompletedRandomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult
Influenza
Phase 22009-12-01
CompletedDAS181 Single Dose Escalation Study in Healthy Adults
Healthy
Phase 12009-05-18
CompletedSingle Dose Escalating Study of DAS181 in Adults
Influenza
Phase 12007-10-01